908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
2012
71
LTM Revenue $58.1M
LTM EBITDA -$38.4M
$17.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
908 Devices has a last 12-month revenue of $58.1M and a last 12-month EBITDA of -$38.4M.
In the most recent fiscal year, 908 Devices achieved revenue of $50.2M and an EBITDA of -$34.0M.
908 Devices expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See 908 Devices valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $46.9M | $50.2M | $57.2M | $58.1M | XXX |
Gross Profit | $23.2M | $26.0M | $25.3M | XXX | XXX |
Gross Margin | 50% | 52% | 44% | XXX | XXX |
EBITDA | -$31.8M | -$34.0M | -$38.8M | -$38.4M | XXX |
EBITDA Margin | -68% | -68% | -68% | -66% | XXX |
Net Profit | -$22.2M | -$33.6M | -$36.4M | XXX | XXX |
Net Margin | -47% | -67% | -64% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 7, 2025, 908 Devices's stock price is $2.
908 Devices has current market cap of $82.2M, and EV of $17.7M.
See 908 Devices trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$17.7M | $82.2M | XXX | XXX | XXX | XXX | $-1.63 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 7, 2025, 908 Devices has market cap of $82.2M and EV of $17.7M.
908 Devices's trades at 0.3x LTM EV/Revenue multiple, and -0.5x LTM EBITDA.
Analysts estimate 908 Devices's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for 908 Devices and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $17.7M | XXX | XXX | XXX |
EV/Revenue | 0.3x | XXX | XXX | XXX |
EV/EBITDA | -0.5x | XXX | XXX | XXX |
P/E | -1.3x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -0.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign Up908 Devices's NTM/LTM revenue growth is 16%
908 Devices's revenue per employee for the last fiscal year averaged $0.7M, while opex per employee averaged $1.0M for the same period.
Over next 12 months, 908 Devices's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate 908 Devices's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for 908 Devices and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 14% | XXX | XXX | XXX | XXX |
EBITDA Margin | -68% | XXX | XXX | XXX | XXX |
EBITDA Growth | 14% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -52% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.7M | XXX | XXX | XXX | XXX |
Opex per Employee | $1.0M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 44% | XXX | XXX | XXX | XXX |
Opex to Revenue | 136% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Electromed | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
908 Devices acquired XXX companies to date.
Last acquisition by 908 Devices was XXXXXXXX, XXXXX XXXXX XXXXXX . 908 Devices acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was 908 Devices founded? | 908 Devices was founded in 2012. |
Where is 908 Devices headquartered? | 908 Devices is headquartered in United States of America. |
How many employees does 908 Devices have? | As of today, 908 Devices has 71 employees. |
Who is the CEO of 908 Devices? | 908 Devices's CEO is Mr. Kevin J. Knopp, PhD. |
Is 908 Devices publicy listed? | Yes, 908 Devices is a public company listed on NAS. |
What is the stock symbol of 908 Devices? | 908 Devices trades under MASS ticker. |
When did 908 Devices go public? | 908 Devices went public in 2020. |
Who are competitors of 908 Devices? | Similar companies to 908 Devices include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem. |
What is the current market cap of 908 Devices? | 908 Devices's current market cap is $82.2M |
What is the current revenue of 908 Devices? | 908 Devices's last 12-month revenue is $58.1M. |
What is the current EBITDA of 908 Devices? | 908 Devices's last 12-month EBITDA is -$38.4M. |
What is the current EV/Revenue multiple of 908 Devices? | Current revenue multiple of 908 Devices is 0.3x. |
What is the current EV/EBITDA multiple of 908 Devices? | Current EBITDA multiple of 908 Devices is -0.5x. |
What is the current revenue growth of 908 Devices? | 908 Devices revenue growth between 2023 and 2024 was 14%. |
Is 908 Devices profitable? | Yes, 908 Devices is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.